MicroRNAs As Mediators and Communicators Between Cancer Cells and the Tumor Microenvironment

Overview

Journal Oncogene

Specialties Molecular Biology
Oncology

Date 2015 Apr 14

PMID 25867073

Citations 121

Authors

F J Kohlhapp

A K Mitra

E Lengyel

M E Peter

Affiliations

Soon will be listed here.

Abstract

Cancer cells grow in an environment comprised of multiple components that support tumor growth and contribute to therapy resistance. Major cell types in the tumor microenvironment are fibroblasts, endothelial cells and infiltrating immune cells all of which communicate with cancer cells. One way that these cell types promote cancer progression is by altering the expression of microRNAs (miRNAs), small noncoding RNAs that negatively regulate protein expression, either in the cancer cells or in the associated normal cells. Changes in miRNA expression can be brought about by direct interaction between the stromal cells and cancer cells, by paracrine factors secreted by any of the cell types or even through direct communication between cells through secreted miRNAs. Understanding the role of miRNAs in the complex interactions between the tumor and cells in its microenvironment is necessary if we are to understand tumor progression and devise new treatments.

Citing Articles

Unveiling cell-type-specific microRNA networks through alternative polyadenylation in glioblastoma.

Cihan M, Schmauck G, Sprang M, Andrade-Navarro M BMC Biol. 2025; 23(1):15.

PMID: 39838429 PMC: 11752630. DOI: 10.1186/s12915-024-02104-8.

Role of exosomes in modulating non-small cell lung cancer radiosensitivity.

Fang J, Rao X, Wang C, Wang Y, Wu C, Zhou R Front Pharmacol. 2024; 15:1471476.

PMID: 39737074 PMC: 11683128. DOI: 10.3389/fphar.2024.1471476.

Exosome therapeutics for non-small cell lung cancer tumorigenesis.

Orooji N, Fadaee M, Kazemi T, Yousefi B Cancer Cell Int. 2024; 24(1):360.

PMID: 39478574 PMC: 11523890. DOI: 10.1186/s12935-024-03544-6.

MiRNAs as Regulators of Immune Cells in the Tumor Microenvironment of Ovarian Cancer.

Wilczynski M, Wilczynski J, Nowak M Cells. 2024; 13(16.

PMID: 39195233 PMC: 11352322. DOI: 10.3390/cells13161343.

Circular RNA as a Biomarker for Diagnosis, Prognosis and Therapeutic Target in Acute and Chronic Lymphoid Leukemia.

Abohassan M, Khaleel A, Pallathadka H, Kumar A, Allela O, Hjazi A Cell Biochem Biophys. 2024; 82(3):1979-1991.

PMID: 39136839 DOI: 10.1007/s12013-024-01404-8.

References

Roccaro A, Sacco A, Maiso P, Azab A, Tai Y, Reagan M . BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression. J Clin Invest. 2013; 123(4):1542-55. PMC: 3613927. DOI: 10.1172/JCI66517. View

He M, Xu Z, Ding T, Kuang D, Zheng L . MicroRNA-155 regulates inflammatory cytokine production in tumor-associated macrophages via targeting C/EBPbeta. Cell Mol Immunol. 2009; 6(5):343-52. PMC: 4003217. DOI: 10.1038/cmi.2009.45. View

Naito Y, Sakamoto N, Oue N, Yashiro M, Sentani K, Yanagihara K . MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer. Cancer Sci. 2013; 105(2):228-35. PMC: 4317817. DOI: 10.1111/cas.12329. View

Zhou W, Fong M, Min Y, Somlo G, Liu L, Palomares M . Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell. 2014; 25(4):501-15. PMC: 4016197. DOI: 10.1016/j.ccr.2014.03.007. View

Calin G, Sevignani C, Dumitru C, Hyslop T, Noch E, Yendamuri S . Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004; 101(9):2999-3004. PMC: 365734. DOI: 10.1073/pnas.0307323101. View

Hu M, Yao J, Cai L, Bachman K, van den Brule F, Velculescu V . Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet. 2005; 37(8):899-905. DOI: 10.1038/ng1596. View

Lin S, Chang D, Lin C, Ying S, Leu D, Wu D . Regulation of somatic cell reprogramming through inducible mir-302 expression. Nucleic Acids Res. 2010; 39(3):1054-65. PMC: 3035461. DOI: 10.1093/nar/gkq850. View

Sugiyama K, Kajiyama H, Shibata K, Yuan H, Kikkawa F, Senga T . Expression of the miR200 family of microRNAs in mesothelial cells suppresses the dissemination of ovarian cancer cells. Mol Cancer Ther. 2014; 13(8):2081-91. DOI: 10.1158/1535-7163.MCT-14-0135. View

Roybal J, Zang Y, Ahn Y, Yang Y, Gibbons D, Baird B . miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1. Mol Cancer Res. 2010; 9(1):25-35. PMC: 3232024. DOI: 10.1158/1541-7786.MCR-10-0497. View

10.

Hu S, Li L, Yeh S, Cui Y, Li X, Chang H . Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11→miRNA-541→androgen receptor (AR)→MMP9 signaling. Mol Oncol. 2014; 9(1):44-57. PMC: 4277919. DOI: 10.1016/j.molonc.2014.07.013. View

11.

Squadrito M, Baer C, Burdet F, Maderna C, Gilfillan G, Lyle R . Endogenous RNAs modulate microRNA sorting to exosomes and transfer to acceptor cells. Cell Rep. 2014; 8(5):1432-46. DOI: 10.1016/j.celrep.2014.07.035. View

12.

Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee J, Lotvall J . Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007; 9(6):654-9. DOI: 10.1038/ncb1596. View

13.

Wang Q, Ni H, Lan L, Wei X, Xiang R, Wang Y . Fra-1 protooncogene regulates IL-6 expression in macrophages and promotes the generation of M2d macrophages. Cell Res. 2010; 20(6):701-12. DOI: 10.1038/cr.2010.52. View

14.

Png K, Halberg N, Yoshida M, Tavazoie S . A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature. 2011; 481(7380):190-4. DOI: 10.1038/nature10661. View

15.

Xu Q, Wang L, Li H, Han Q, Li J, Qu X . Mesenchymal stem cells play a potential role in regulating the establishment and maintenance of epithelial-mesenchymal transition in MCF7 human breast cancer cells by paracrine and induced autocrine TGF-β. Int J Oncol. 2012; 41(3):959-68. DOI: 10.3892/ijo.2012.1541. View

16.

Lee J, Park S, Jung B, Jeon Y, Lee Y, Kim M . Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells. PLoS One. 2014; 8(12):e84256. PMC: 3877259. DOI: 10.1371/journal.pone.0084256. View

17.

Jusufovic E, Rijavec M, Keser D, Korosec P, Sodja E, Iljazovic E . let-7b and miR-126 are down-regulated in tumor tissue and correlate with microvessel density and survival outcomes in non--small--cell lung cancer. PLoS One. 2012; 7(9):e45577. PMC: 3454421. DOI: 10.1371/journal.pone.0045577. View

18.

Wei J, Wang F, Kong L, Xu S, Doucette T, Ferguson S . miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma. Cancer Res. 2013; 73(13):3913-26. PMC: 3780786. DOI: 10.1158/0008-5472.CAN-12-4318. View

19.

Fang L, Du W, Yang W, Rutnam Z, Peng C, Li H . MiR-93 enhances angiogenesis and metastasis by targeting LATS2. Cell Cycle. 2012; 11(23):4352-65. PMC: 3552918. DOI: 10.4161/cc.22670. View

20.

Junttila M, de Sauvage F . Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 2013; 501(7467):346-54. DOI: 10.1038/nature12626. View